JMP Securities analyst Jonathan Wolleben reiterated a Buy rating on Rallybio (RLYB – Research Report) today and set a price target of $7.00.

JMP Securities analyst Jonathan Wolleben reiterated a Buy rating on KalVista Pharmaceuticals (KALV – Research Report) today and set a price ...

uninterruptible power supplies, generators, and automotive tech. Most recently, he was Section Editor, Mobile at Digital Trends, spearheading his team's coverage of breaking news, features ...

Cut costs and development time with low-code tools. Do more with your data by using a low-code platform to secure and manage apps, workflows, and AI-powered tools. Find out why Everest Group named ...